Register to get unlimited access to our investor forum and all editorial content, including our e-zine and weekly email. Registration is free and only takes a minute.
Showing fund managers & funds available in Investment Trust Insider. View fund & fund manager rankings globally

Funds & Fund Managers

All calculations in GBP, unless stated
over :
 Average Manager Total Return : 5.5% (30 April 2017 - 30 April 2018)
Total Return
1 of 102

19.8%

2 of 102

14.4%

3 of 102

13.9%

3 of 102

13.9%

5 of 102

13.2%

6 of 102

13.0%

6 of 102

13.0%

8 of 102

12.3%

9 of 102

12.1%

10 of 102

11.6%

11 of 102

10.3%

11 of 102

10.3%

13 of 102

10.0%

13 of 102

10.0%

15 of 102

9.7%

16 of 102

9.2%

17 of 102

9.2%

18 of 102

8.8%

19 of 102

8.6%

20 of 102

8.4%

20 of 102

8.4%

22 of 102

8.1%

23 of 102

7.9%

24 of 102

7.9%

25 of 102

7.7%

26 of 102

7.5%

27 of 102

7.5%

28 of 102

7.4%

29 of 102

7.4%

30 of 102

7.2%

31 of 102

7.2%

32 of 102

7.1%

33 of 102

7.0%

33 of 102

7.0%

33 of 102

7.0%

36 of 102

7.0%

37 of 102

6.9%

37 of 102

6.9%

37 of 102

6.9%

37 of 102

6.9%

41 of 102

6.6%

42 of 102

6.2%

42 of 102

6.2%

42 of 102

6.2%

45 of 102

6.2%

46 of 102

5.9%

46 of 102

5.9%

46 of 102

5.9%

49 of 102

5.9%

50 of 102

5.7%

51 of 102

5.6%

52 of 102

5.5%

53 of 102

5.4%

54 of 102

5.1%

55 of 102

5.0%

55 of 102

5.0%

57 of 102

5.0%

58 of 102

4.8%

59 of 102

4.8%

59 of 102

4.8%

61 of 102

4.7%

61 of 102

4.7%

63 of 102

4.6%

64 of 102

4.6%

65 of 102

4.5%

65 of 102

4.5%

67 of 102

4.4%

67 of 102

4.4%

69 of 102

4.4%

69 of 102

4.4%

69 of 102

4.4%

69 of 102

4.4%

73 of 102

4.2%

74 of 102

4.0%

75 of 102

3.9%

76 of 102

3.8%

76 of 102

3.8%

78 of 102

3.4%

78 of 102

3.4%

80 of 102

3.3%

81 of 102

2.9%

82 of 102

2.5%

83 of 102

2.3%

84 of 102

2.2%

85 of 102

1.5%

86 of 102

0.9%

86 of 102

0.9%

88 of 102

0.7%

88 of 102

0.7%

90 of 102

0.6%

91 of 102

0.5%

92 of 102

0.3%

93 of 102

-0.2%

94 of 102

-0.4%

95 of 102

-0.6%

96 of 102

-1.3%

97 of 102

-1.9%

98 of 102

-2.2%

99 of 102

-2.3%

100 of 102

-3.2%

101 of 102

-10.2%

102 of 102

-11.1%

Managers with less than 12 months history are below. View 1 month performance
Show more managers
Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated). Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.

Bullish Robinson off to a flyer on Baillie Gifford US Growth

'I don't think I've been more bullish than I am right now' says Gary Robinson as shares in his Baillie Gifford US Growth trust get off to a strong start.

Ranger Direct Lending sacks manager and abandons P2P

Troubled peer-to-peer investment company backed by Invesco’s Mark Barnett serves notice on its fund manager and looks to switch to secured loans with Ares Credit.

The hedge fund that's beaten Woodford twice

Small US hedge fund Kerrisdale Capital has been on the winning side of two high-profile clashes with Neil Woodford.

Woodford Patient Capital: battered shares draw in bargain hunters

(Update) Woodford Patient Capital Trust marks its third birthday with its shares still marooned below their launch price but with some investors spotting a buying opportunity.

Woodford Patient Capital plunges as Prothena trial fails

Prothena, one of the big biotech bets of fund manager Neil Woodford, has failed a key drugs test, wiping two thirds from its market value and souring third anniversary of his Woodford Patient Capital Trust.

Fund managers lick wounds after Conviviality collapse

'We are very sorry', say Acorn Income managers, while Marlborough's Siddarth Chand Lall labels investment 'a hard and painful lesson'.

Investment trusts dominate AJ Bell’s list of best-selling ISAs

Excluding direct equities, six of the 10 most popular investments on the AJ Bell broking platform in the first quarter were investment trusts.

Key Woodford stock in cancer therapy breakthrough

Proton Partners International has used its proton beam therapy on its first UK cancer patient.

Miton UK MicroCap shareholders head for the exit

Shareholders in smaller companies trust run by Gervais Williams and Martin Turner have requested to sell over 10% of their stake in its annual redemption facility.

Woodford Patient shares soar on $2.2bn biotech tie-up

Shares in Woodford Patient Capital trust surge as top holding announces biotech tie-up that could be worth up to $2.2 billion.